McKesson Cost of Goods Sold 2010-2024 | MCK
McKesson annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- McKesson cost of goods sold for the quarter ending June 30, 2024 was $76.131B, a 6.54% increase year-over-year.
- McKesson cost of goods sold for the twelve months ending June 30, 2024 was $300.793B, a 10.71% increase year-over-year.
- McKesson annual cost of goods sold for 2024 was $296.123B, a 12.02% increase from 2023.
- McKesson annual cost of goods sold for 2023 was $264.353B, a 5.39% increase from 2022.
- McKesson annual cost of goods sold for 2022 was $250.836B, a 10.95% increase from 2021.
McKesson Annual Cost of Goods Sold
(Millions of US $) |
| 2024 |
$296,123 |
| 2023 |
$264,353 |
| 2022 |
$250,836 |
| 2021 |
$226,080 |
| 2020 |
$219,028 |
| 2019 |
$202,565 |
| 2018 |
$197,173 |
| 2017 |
$187,262 |
| 2016 |
$179,468 |
| 2015 |
$167,634 |
| 2014 |
$129,040 |
| 2013 |
$115,315 |
| 2012 |
$115,919 |
| 2011 |
$106,114 |
| 2010 |
$103,026 |
| 2009 |
$101,254 |
McKesson Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-06-30 |
$76,131 |
| 2024-03-31 |
$72,770 |
| 2023-12-31 |
$77,746 |
| 2023-09-30 |
$74,146 |
| 2023-06-30 |
$71,461 |
| 2023-03-31 |
$65,844 |
| 2022-12-31 |
$67,316 |
| 2022-09-30 |
$67,062 |
| 2022-06-30 |
$64,131 |
| 2022-03-31 |
$62,784 |
| 2021-12-31 |
$65,186 |
| 2021-09-30 |
$63,224 |
| 2021-06-30 |
$59,642 |
| 2021-03-31 |
$55,845 |
| 2020-12-31 |
$59,448 |
| 2020-09-30 |
$57,808 |
| 2020-06-30 |
$52,979 |
| 2020-03-31 |
$55,199 |
| 2019-12-31 |
$56,139 |
| 2019-09-30 |
$54,749 |
| 2019-06-30 |
$52,941 |
| 2019-03-31 |
$49,228 |
| 2018-12-31 |
$53,238 |
| 2018-09-30 |
$50,271 |
| 2018-06-30 |
$49,828 |
| 2018-03-31 |
$48,553 |
| 2017-12-31 |
$50,902 |
| 2017-09-30 |
$49,227 |
| 2017-06-30 |
$48,491 |
| 2017-03-31 |
$45,917 |
| 2016-12-31 |
$47,318 |
| 2016-09-30 |
$47,201 |
| 2016-06-30 |
$46,826 |
| 2016-03-31 |
$43,826 |
| 2015-12-31 |
$45,027 |
| 2015-09-30 |
$45,917 |
| 2015-06-30 |
$44,698 |
| 2015-03-31 |
$42,008 |
| 2014-12-31 |
$43,586 |
| 2014-09-30 |
$41,296 |
| 2014-06-30 |
$40,744 |
| 2014-03-31 |
$35,281 |
| 2013-12-31 |
$32,486 |
| 2013-09-30 |
$30,964 |
| 2013-06-30 |
$30,309 |
| 2013-03-31 |
$28,651 |
| 2012-12-31 |
$29,454 |
| 2012-09-30 |
$28,072 |
| 2012-06-30 |
$29,138 |
| 2012-03-31 |
$29,606 |
| 2011-12-31 |
$29,273 |
| 2011-09-30 |
$28,569 |
| 2011-06-30 |
$28,471 |
| 2011-03-31 |
$27,102 |
| 2010-12-31 |
$26,786 |
| 2010-09-30 |
$26,168 |
| 2010-06-30 |
$26,058 |
| 2010-03-31 |
$25,060 |
| 2009-12-31 |
$26,817 |
| 2009-09-30 |
$25,795 |
| 2009-06-30 |
$25,354 |
| 2009-03-31 |
$24,759 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$66.345B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
